default author photo

Damien Vansteene

Institut de Cancérologie de l’Ouest René Gauducheau - Department of Medical Oncology

France

SCHOLARLY PAPERS

2

DOWNLOADS

184

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Cetuximab, Docetaxel and Cisplatin as First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Results of the GORTEC 2014-01 TPExtreme Randomized Trial

Number of pages: 31 Posted: 05 Oct 2020
Centre Antoine Lacassagne - Department of Medical Oncology, University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy, University of Claude Bernard Lyon 1 - Medical Oncology Department, Centre Antoine Lacassagne, ILC Centre Jean Bernard/Clinique Victor Hugo - Department of Medical Oncology, Institut Català de Oncologia - Department of Medical Oncology, Institut de Cancérologie de Lorraine - Department of Medical Oncology, Clinique des Ormeaux - Department of Medical Oncology, Institut de Cancérologie de l’Ouest Paul Papin - Department of Medical Oncology, Institut de Cancérologie de Montpellier - Department of Medical Oncology, Hôpital Privé le Confluent - Department of Medical Oncology, Institut de Cancérologie de l’Ouest René Gauducheau - Department of Medical Oncology, Centre Antoine Lacassagne - Department of Medical Oncology, Centre François Baclesse - Department of Medical Oncology, Gustave Roussy - Department of Head and Neck Oncology, Centre Hospitalier de Bretagne Sud - Department of Medical Oncology, Hôpital de la Croix Rousse - Department of Medical Oncology, Université de Poitiers - Medical Oncology Department, Institut Claudius Regaud - Department of Medical Oncology, Centre Eugène Marquis - Department of Medical Oncology, Centre Georges-François Leclerc - Department of Medical Oncology, University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy, University Paris-Saclay - Biostatistic and Epidemiology Unit, Gustave Roussy, Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), Charité Comprehensive Cancer Center, Groupe d'Oncologie Radiothérapie Tête et Cou (GORTEC), Autonomous University of Barcelona - Medical Oncology Department and Independent
Downloads 111 (635,507)

Abstract:

Loading...

head and neck cancer, squamous cell carcinoma, recurrent, metastatic, Chemotherapy, cetuximab, taxane.

2.

Hpv Circulating Tumor DNA to Monitor Response to Pembrolizumab and Vorinostat Combination in Patients with Advanced Hpv-Related Squamous Cell Carcinomas

Number of pages: 28 Posted: 21 Mar 2025
Fondazione IRCCS Istituto Nazionale dei Tumori, affiliation not provided to SSRN, PSL Research University - Institut Curie, PSL Research University - Institut Curie, Centre François Baclesse - Department of Medical Oncology, PSL Research University - Institut Curie, European Institute of Oncology (IEO) IRCCS - Department of Experimental Oncology, PSL Research University - Institut Curie, PSL Research University - Institut Curie, affiliation not provided to SSRN, PSL Research University - Institut Curie, Université Lyon 1 - Faculty of Medicine Lyon-Sud, affiliation not provided to SSRN, Centre Georges-François Leclerc - Department of Medical Oncology, Institut de Cancérologie de l’Ouest René Gauducheau - Department of Medical Oncology, affiliation not provided to SSRN, University of Bordeaux - Institut Bergonié, CHU Nancy, Centre Antoine Lacassagne, Centre Jean Perrin, University of Lille II - Centre Oscar Lambret, Institut de cancérologie Strasbourg Europe (ICANS), affiliation not provided to SSRN, PSL Research University - Institut Curie, UNICANCER, Leipzig University, UNICANCER, PSL Research University - Institut Curie, affiliation not provided to SSRN, Institut Curie, PSL Research University - Institut Curie and PSL Research University - Institut Curie
Downloads 73 (852,604)

Abstract:

Loading...

circulating tumor DNA, HPV, squamous cell carcinoma, biomarker, pharmacodynamic, immunotherapy